Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3

Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sannino, Mario, Lodi, Giuseppe, Dethlefsen, Markus Wied, Nisticò, Steven Paul, Cannarozzo, Giovanni, Nielsen, Michael Canova Engelbrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293188/
https://www.ncbi.nlm.nih.gov/pubmed/30564333
http://dx.doi.org/10.1002/ccr3.1891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293188/
https://www.ncbi.nlm.nih.gov/pubmed/30564333
http://dx.doi.org/10.1002/ccr3.1891

Ejemplares similares